Selective CD28 Blockade in Renal Transplant Recipients
Stopped Limited period of availability of a supply of the study drug and difficulties in enrollment
Conditions
- Kidney Transplantation
- Renal Transplant Recipients
Interventions
- BIOLOGICAL: Lulizumab
- DRUG: Tacrolimus
- BIOLOGICAL: Thymoglobulin®
- DRUG: Methylprednisolone
- DRUG: Mycophenolate Mofetil
- DRUG: Prednisone
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
- [object Object]
- [object Object]